Ann: MDR Jun-17 Quarterly Report & 4C, page-11

@futurenow I worry about these claims of added users? Just because they got access to xxx users through an acquisition, isn't the more important data "active users"? That is, how many are actively using the product each month not how many are "signed up? I note no such stat is actually provided yet active users is always the more important stat as is the degree to which folks are "repeat" users of an app.

Also, I note that Chemist Warehouse have licensed access to their own medication management solution in their app, built apparently by another Australian company who I think may be intending to bring this to their other pharmacy clients, and that the Pharmacy Guild also have a competing product, and that by MDR terminating their relationship with the Guild may now have a competitor with that very group now?

Data on the competition in the market in this space does not seem to be discussed?

I have not yet invested in MDR, but have been following it closely. Its an interesting space.

the data on revenue that is available though does not provide a lot of insight into organic revenue growth from increased activities vs growth in other stats?

You also make the statement "MDR is now clearly the dominant and incumbent provider of health integration". What do you base this on?

thanks!